Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Conditions

• Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

Interventions

• RADIATION: Stereotactic radiotherapy
• DRUG: Evoximab
• DRUG: Pemetrexed
• DRUG: Albumin Paclitaxel
• DRUG: Carboplatin

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School